WO1988009378A3 - Polypeptide code par un oncogene et presentant une activite de facteur de croissance, ses procedes de production et d'utilisation - Google Patents
Polypeptide code par un oncogene et presentant une activite de facteur de croissance, ses procedes de production et d'utilisation Download PDFInfo
- Publication number
- WO1988009378A3 WO1988009378A3 PCT/US1988/001767 US8801767W WO8809378A3 WO 1988009378 A3 WO1988009378 A3 WO 1988009378A3 US 8801767 W US8801767 W US 8801767W WO 8809378 A3 WO8809378 A3 WO 8809378A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- growth factor
- methods
- factor activity
- oncogene
- polypeptide
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 239000003102 growth factor Substances 0.000 title abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP88907473A EP0317627B1 (fr) | 1987-05-29 | 1988-05-26 | Polypeptide code par un oncogene et presentant une activite de facteur de croissance, ses procedes de production et d'utilisation |
DE3854420T DE3854420T2 (de) | 1987-05-29 | 1988-05-26 | Onkogen kodierendes polypeptid, das wachstumsfaktoraktivität besitzt, verfahren zu seiner herstellung und verwendung. |
DK198900388A DK175211B1 (da) | 1987-05-29 | 1989-01-27 | Onkogen-indkodet polypeptid med vækstfaktoraktivitet, nucleinsyremolekyle kodende herfor, vektor indeholdende nucleinsyremolekylet, værtscellesystem indeholdende vektoren, fremgangsmåde til fremstilling af polypeptidet, præparat indeholdende...... |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/056,137 US5155217A (en) | 1987-05-29 | 1987-05-29 | Ongogene encoding polypeptide having growth factor activity |
US056,137 | 1987-05-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1988009378A2 WO1988009378A2 (fr) | 1988-12-01 |
WO1988009378A3 true WO1988009378A3 (fr) | 1988-12-15 |
Family
ID=22002413
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1988/001767 WO1988009378A2 (fr) | 1987-05-29 | 1988-05-26 | Polypeptide code par un oncogene et presentant une activite de facteur de croissance, ses procedes de production et d'utilisation |
Country Status (9)
Country | Link |
---|---|
US (1) | US5155217A (fr) |
EP (1) | EP0317627B1 (fr) |
JP (1) | JP2888846B2 (fr) |
AT (1) | ATE127478T1 (fr) |
AU (1) | AU626268B2 (fr) |
CA (1) | CA1340374C (fr) |
DE (1) | DE3854420T2 (fr) |
DK (1) | DK175211B1 (fr) |
WO (1) | WO1988009378A2 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7238673B2 (en) | 1989-03-31 | 2007-07-03 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
JP2784272B2 (ja) * | 1990-06-06 | 1998-08-06 | 大正製薬株式会社 | 腫瘍細胞増殖阻害因子 |
US6551618B2 (en) | 1994-03-15 | 2003-04-22 | University Of Birmingham | Compositions and methods for delivery of agents for neuronal regeneration and survival |
US6331523B1 (en) | 1998-03-12 | 2001-12-18 | Genentech, Inc. | Method of enhancing the survival of retinal neurons and treating ocular diseases using FGF-5 |
US8618052B2 (en) | 1998-10-13 | 2013-12-31 | Novartis Vaccines And Diagnostics, Inc. | Method of treating coronary artery disease by administering FGF-5 |
US6440934B1 (en) | 1998-10-13 | 2002-08-27 | Chiron Corporation | Angiogenically effective unit dose of FGF-2 and method of use |
WO2000021548A2 (fr) | 1998-10-13 | 2000-04-20 | Chiron Corporation | Dose unitaire de fgf efficace du point de vue angiogenique et methode d'administration |
US20030166550A1 (en) * | 1999-08-27 | 2003-09-04 | Chiron Corporation | Angiogenically effective unit dose of FGF-2 and method of use |
US20020072489A1 (en) * | 1998-10-13 | 2002-06-13 | Whitehouse Martha J. | Angiogenically effective unit dose of FGF-2 and method of use |
WO2001013031A2 (fr) | 1999-08-13 | 2001-02-22 | Chiron Corporation | Dose d'un facteur angiogenique et procede d'administration correspondant destines a ameliorer le debit sanguin du myocarde |
US20060009393A1 (en) * | 1999-10-02 | 2006-01-12 | The Government of the U.S.A as represented by the Secretary of the Dept. of Health & Human Services | Immunogenic epitopes for fibroblast growth factors 5 (FGF-5) |
-
1987
- 1987-05-29 US US07/056,137 patent/US5155217A/en not_active Expired - Lifetime
-
1988
- 1988-05-26 AU AU22628/88A patent/AU626268B2/en not_active Expired
- 1988-05-26 WO PCT/US1988/001767 patent/WO1988009378A2/fr active IP Right Grant
- 1988-05-26 EP EP88907473A patent/EP0317627B1/fr not_active Expired - Lifetime
- 1988-05-26 AT AT88907473T patent/ATE127478T1/de not_active IP Right Cessation
- 1988-05-26 DE DE3854420T patent/DE3854420T2/de not_active Expired - Lifetime
- 1988-05-26 JP JP63506808A patent/JP2888846B2/ja not_active Expired - Lifetime
- 1988-05-27 CA CA000567999A patent/CA1340374C/fr not_active Expired - Fee Related
-
1989
- 1989-01-27 DK DK198900388A patent/DK175211B1/da not_active IP Right Cessation
Non-Patent Citations (11)
Title |
---|
Cell, (Cambridge, Massachusetts, USA) Volume 50, issued August 1987, (BOVI et al.), "An Oncogene Isolated by Transfection of Kaposi's Sarcoma DNA Encodes a Growth Factor that is a Member of the FGF Family", see page 729. * |
Molecular and Cellular Biology, (Washington, D.C. U.S.A.), Volume 6, issued October 1986, (ZHAN et al.), "Growth Factor Requirements of Oncogene-Transformed NIH3T3 and Balb/c 3T3 Cells Culture in Defined Media", see page 3541. * |
Molecular and Cellular Biology, (Washington, D.C., U.S.A.), Volume 6, issued October 1986, (VOGT et al.), "Coinfection with Viruses Carrying the v-Ha-Ras and v-Myc Oncogenes Leads to Growth Factor Independence by an Indirect Mechanism", see page 3545. * |
Nature, (London, England), Volume 300, issued 9 December 1982, (PULCIANI et al.), "Oncogenes in Solid Human Tumours", see page 539. * |
Nature, (London, England), Volume 303, issued 2 June 1983, (HALL et al.), "Identification of Transforming Gene in two Human Sarcoma Cell Lines as a New Member of the Ras Gene Family Located on Chromosome 1", see pages 396 and 397. * |
Nature, (London, England), Volume 316, issued 18 July 1985, (EVA et al.), "Isolation of a New Oncogene from a Diffuse B-Cell Lymphoma", see page 273. * |
Nature, (London, England), Volume 326, issued 30 April 1987, (DICKSON et al.) "Potential Oncogene Product Related to Growth Factors", see page 833 * |
Proceedings of the National Academy of Sciences, (Washington, D.C., USA) Volume 82, issued September 1985, (FUKUI et al.), "Detection of Raf-Related and two other Transforming DNA Sequences in Human Tumors Maintained in Nude Mile", see page 5854. * |
Science, (Washington, D.C. U.S.A.), Volume 230, issued 20 December 1985, (GIMENEZ-GALLEGO) "Brain-Derived Acidic Firboblast Growth Factor: Complete Amino Acid Sequence and Homologies", see page 1385. * |
Science, (Washington, D.C., U.S.A.), Volume 233, issued 1 August 1986, (ABRAHAM et al.), "Nucleotide Sequence of a Bovine Clone Encoding the Angiogenic Protein, Basic Fibroblast Growth Factor", see page 545. * |
The EMBO Journal, (Oxford, England) Volume 5, issue May 1986, (MOORE et al) "Sequence, Topagraphy, and Protein Coding Potential of Int-2: a Putative Oncogene Activated by Mouse Mammary Tumour Virus", see page 729. * |
Also Published As
Publication number | Publication date |
---|---|
AU626268B2 (en) | 1992-07-30 |
US5155217A (en) | 1992-10-13 |
CA1340374C (fr) | 1999-02-02 |
DE3854420T2 (de) | 1996-05-02 |
AU2262888A (en) | 1988-12-21 |
EP0317627A4 (en) | 1990-12-12 |
ATE127478T1 (de) | 1995-09-15 |
WO1988009378A2 (fr) | 1988-12-01 |
DK38889A (da) | 1989-01-27 |
EP0317627A1 (fr) | 1989-05-31 |
DE3854420D1 (de) | 1995-10-12 |
DK175211B1 (da) | 2004-07-12 |
JPH01503518A (ja) | 1989-11-30 |
EP0317627B1 (fr) | 1995-09-06 |
JP2888846B2 (ja) | 1999-05-10 |
DK38889D0 (da) | 1989-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG49097A1 (en) | Nucleotide sequences coding for a protein with urease activity | |
TW327194B (en) | Novel amyloid precursor proteins and methods of using same | |
CA2253238A1 (fr) | Nouveau gene apparente a l'agouti | |
CA2141060A1 (fr) | Insertion de gmp cyclique; phosphodiesterase et methodes specifiques pour gmp cyclique | |
HUT46061A (en) | Dna sequences encoding hirudin-like protein and process for producing such proteins | |
ATE125867T1 (de) | Fibronektinbindungsprotein und dessen herstellung. | |
CA2267670A1 (fr) | Methode pour preparer des cellules humaines a facteur souches polypeptide | |
EP0182372A3 (fr) | Polypeptides facteur VIII coagulant | |
CA2177827A1 (fr) | Nouvelles proteines modulant l'apoptose, adn codant pour ces proteines, et leur mode d'utilisation | |
CA2180103A1 (fr) | Gene codant par les adseverines | |
WO1988009378A3 (fr) | Polypeptide code par un oncogene et presentant une activite de facteur de croissance, ses procedes de production et d'utilisation | |
AU1562988A (en) | DNA clone of human thrombomodulin | |
CA2167693A1 (fr) | Proteine inhibitrice de melanomes | |
MX9708426A (es) | Polipeptido hk2 de variante estable. | |
DE3853446D1 (de) | Fibronectinbindungsprotein und dessen Herstellung. | |
AU3346289A (en) | Heparin-binding proteins, DNA coding for them, processes for producing them as well as therapeutic preparations containing them | |
AU2795989A (en) | Production of gonorrheal pi proteins and vaccines | |
CS8708732A2 (en) | Method of hv1, hv2, hv3 hirodin forms' one variant production | |
EP0546087A4 (fr) | ||
DE3783145D1 (de) | Rekombinantes dns-plasmid zur herstellung von xanthangummi. | |
AU5727099A (en) | A 2,6-beta-d-fructan hydrolase enzyme and processes for using the enzyme | |
EP0297585A3 (fr) | Polypeptide neuronal et méthode pour sa production et son utilisation | |
DE3886234D1 (de) | DNA-Sequenzen, Plasmide und Mikroorganismen sowie Verfahren zur Herstellung von Chinolinsäure. | |
DE3888216D1 (de) | Methode zur Herstellung von aminokohlenwasserstoff-substituierten Ketoximosilanen. | |
DE58906674D1 (de) | Verfahren zur Auswahl produktiver, Aminosäuren ausscheidender Stämme von Mikroorganismen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU DK JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU DK JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1988907473 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1988907473 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1988907473 Country of ref document: EP |